Phosphorothioate backbone modification modulates macrophage activation by CpG DNA

Journal of Immunology

Volumn 165, Issue 8, 2000, Pages 4165-4173

  Sester, D P ^a   Naik, S ^a   Beasley, S J ^a   Hume, D A ^a   Stacey, K J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INTERLEUKIN 12; LUCIFERASE; NITRIC OXIDE; OLIGODEOXYNUCLEOTIDE; PHOSPHOROTHIOIC ACID;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL VIABILITY; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN TRANSPORT;

EID: 0034667770     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.8.4165     Document Type: Article

References (50)

1. Immune recognition of foreign DNA: A cure for bioterrorism?
2. The role of CpG dinucleotides in DNA vaccines
3. Mechanisms and therapeutic applications of immune stimulatory CpG DNA
4. Immunostimulatory DNA sequences function as T helper-1 promoting adjuvants
5. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th 1) immunity
6. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
7. Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major
8. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides
9. Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway
10. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice
11. Pharmacokinetics of antisense oligonucleotides
12. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
13. Characterization and modulation of immune stimulation by modified oligonucleotides
14. Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation
15. Influence of backbone chemistry on immune activation by synthetic oligonucleotides
16. Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1
17. Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs
18. Immune stimulation: A class effect of phosphorothioate oligodeoxynucleotides in rodents
19. Activation of human B cells by phosphorothioate oligodeoxynucleotides
20. Mechanism of action of CpG DNA
21. Macrophages ingest and are activated by bacterial DNA
22. Macrophages sense pathogens via DNA motifs: Induction of tumor necrosis factor
23. IFN-γ primes macrophage responses to bacterial DNA
24. Macrophage activation by immunostimulatory DNA
25. Differential regulation of the IL-12 p40 promoter and of p40 secretion by CpG DNA and lipopolysaccharide
26. Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony stimulating factor
27. RAW264 macrophages stably transfected with an HIV-1 LTR reporter gene provide a sensitive bioassay for analysis of signalling pathways in macrophages stimulated with lipopolysaccharide, TNF-α or taxol
28. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry
29. Lipofection of synthetic oligodeoxynucleotide having palindromic sequence of AACGTT to murine splenocytes enhances interferon production and natural killer activity
30. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens
31. Electroporation and DNA-dependent cell death in murine macrophages
32. Bacterial/CpG DNA down-modulates colony stimulating factor-1 receptor surface expression on murine bone marrow-derived macrophages with concomitant growth arrest and factor-independent survival
33. Cellular uptake mechanism for oligonucleotides: Involvement of endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal adenocarcinoma cell line, HCT-15
34. 1 renal epithelial cells
35. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides
36. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation
37. Phosphorothioate analogs of oligodeoxynucleotides: Inhibitors of replication and cytopathic effects of human immunodeficiency virus
38. Cellular pharmacology of phosphorothioate homooligodeoxynucleotides in human cells
39. Involvement of Ets, rel and Sp1-like proteins in lipopolysaccharide-mediated activation of the HIV-1 LTR in macrophages
40. Both PU.1 and nuclear factor-κB mediate lipopolysaccharide-induced HIV-1 long terminal repeat transcription in macrophages
41. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides
42. As nature intended? The uptake of DNA and oligonucleotides by eukaryotic cells
43. Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein
44. Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: Dependence on phosphorothioate modification and reversal by heparin
45. Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides
46. Non-antisense effects of antisense oligonucleotides
47. Phosphorothioate antisense oligodeoxynucleotides: Questions of specificity
48. Effects of suramin-related and other clinically therapeutic polyanions on protein kinase C activity
49. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides
50. Activation of macrophages and B lymphocytes by an oligodeoxynucleotide derived from an acutely pathogenic simian immunodeficiency virus